Free Trial

Public Employees Retirement System of Ohio Purchases Shares of 20,590 Amedisys, Inc. (NASDAQ:AMED)

Amedisys logo with Medical background

Public Employees Retirement System of Ohio bought a new stake in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 20,590 shares of the health services provider's stock, valued at approximately $1,869,000. Public Employees Retirement System of Ohio owned approximately 0.06% of Amedisys at the end of the most recent quarter.

A number of other large investors have also recently modified their holdings of the stock. Trexquant Investment LP increased its holdings in Amedisys by 1,317.8% during the fourth quarter. Trexquant Investment LP now owns 87,719 shares of the health services provider's stock valued at $7,964,000 after buying an additional 81,532 shares during the last quarter. ABC Arbitrage SA bought a new position in shares of Amedisys during the fourth quarter worth $2,522,000. Schonfeld Strategic Advisors LLC boosted its position in shares of Amedisys by 17.5% during the fourth quarter. Schonfeld Strategic Advisors LLC now owns 4,500 shares of the health services provider's stock worth $409,000 after acquiring an additional 671 shares during the last quarter. Deutsche Bank AG boosted its position in shares of Amedisys by 22.7% during the fourth quarter. Deutsche Bank AG now owns 2,524 shares of the health services provider's stock worth $229,000 after acquiring an additional 467 shares during the last quarter. Finally, Empowered Funds LLC bought a new position in Amedisys during the fourth quarter valued at $318,000. Institutional investors own 94.36% of the company's stock.

Analysts Set New Price Targets

Several equities analysts have commented on the company. Stephens reaffirmed an "equal weight" rating and issued a $101.00 price objective on shares of Amedisys in a research report on Tuesday, March 4th. Wall Street Zen downgraded Amedisys from a "strong-buy" rating to a "buy" rating in a research note on Saturday, May 24th. Finally, Royal Bank of Canada restated an "outperform" rating and issued a $100.00 price objective on shares of Amedisys in a research report on Wednesday, April 16th. Four equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average price target of $100.75.

View Our Latest Analysis on AMED

Amedisys Stock Down 0.7%

Shares of NASDAQ:AMED traded down $0.69 during trading hours on Thursday, reaching $93.88. The stock had a trading volume of 160,351 shares, compared to its average volume of 409,812. Amedisys, Inc. has a 1 year low of $82.15 and a 1 year high of $98.95. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.19 and a current ratio of 1.19. The stock has a market capitalization of $3.08 billion, a price-to-earnings ratio of 37.25, a P/E/G ratio of 1.78 and a beta of 0.96. The firm's 50 day moving average is $93.62 and its 200-day moving average is $91.69.

Amedisys (NASDAQ:AMED - Get Free Report) last announced its earnings results on Wednesday, April 23rd. The health services provider reported $1.25 EPS for the quarter, beating analysts' consensus estimates of $1.13 by $0.12. Amedisys had a net margin of 3.57% and a return on equity of 12.20%. The business had revenue of $594.78 million for the quarter, compared to analysts' expectations of $597.43 million. During the same period in the previous year, the company posted $1.03 EPS. The company's quarterly revenue was up 4.1% on a year-over-year basis. Research analysts predict that Amedisys, Inc. will post 4.4 earnings per share for the current fiscal year.

Amedisys Company Profile

(Free Report)

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.

Further Reading

Institutional Ownership by Quarter for Amedisys (NASDAQ:AMED)

Should You Invest $1,000 in Amedisys Right Now?

Before you consider Amedisys, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amedisys wasn't on the list.

While Amedisys currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks to BUY NOW in July 2025
3 Defense Stocks Under $10 With Massive Upside
NVIDIA: Another 200% Growth Ahead? (PLUS 2 Companies Riding Along)

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines